Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis

Published:2017-03 Issue:6 Volume:168 Page:1101-1113.e13
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Boire Adrienne,Zou Yilong,Shieh Jason,Macalinao Danilo G.,Pentsova Elena,Massagué Joan

Funder

NIH

DOD

Alan and Sandra Gerry Metastasis Research Initiative

MSKCC Clinical Scholars Training Program

Solomon R. and Rebecca D. Baker Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference64 articles.

1. A CXCL1 paracrine network links cancer chemoresistance and metastasis;Acharyya;Cell,2012

2. Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21;Addison;J. Clin. Oncol.,2010

3. Molecular cloning and characterization of the human anaphylatoxin C3a receptor;Ames;J. Biol. Chem.,1996

4. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models;Ames;J. Immunol.,2001

5. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients;An;Int. J. Cancer,2015

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma Brain Metastasis;Hematology/Oncology Clinics of North America;2024-10

2. Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS‐mutant Cancers;Advanced Science;2024-09-10

3. Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study;Neuro-Oncology;2024-08-07

4. Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC;Cell Reports;2024-08

5. The complement system in neurodegenerative and inflammatory diseases of the central nervous system;Frontiers in Neurology;2024-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3